Gregory Madden

Has grant

Assistant Professor

University of Virginia

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Gregory Madden is an Assistant Professor at the University of Virginia, United States. His research primarily focuses on Clostridioides difficile infections, with recent publications addressing prediction models, treatment outcomes, and the use of machine learning in risk assessment. He is also involved in projects related to methicillin-resistant Staphylococcus aureus, exploring clinical risk tools and infection management strategies.

Recent Grants

Grant: Close

Training Grant

Open Date: 2017-07-01

Close Date: 2020-06-01

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (3)

Jiaming Cui

Assistant Professor

Virginia Tech

UNITED STATES

View details

Anil Kumar Vullikanti

University of Virginia

UNITED STATES

View details

Costi D. Sifri

University of Virginia School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gregory Madden

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Anti-interleukin-23 treatment linked to improved Clostridioides difficile infection survival

Predicting Clostridioides difficile infection outcomes with explainable machine learning

Improving Risk Prediction of Methicillin-Resistant Staphylococcus aureus Using Machine Learning Methods With Network Features: Retrospective Development Study

Validation of clinical risk tools for recurrent Clostridioides difficile infection

Modeling relaxed policies for discontinuation of methicillin-resistant Staphylococcus aureus contact precautions

Novel Biomarkers, Including tcdB PCR Cycle Threshold, for Predicting Recurrent Clostridioides difficile Infection

Validation of Clinical Risk Models for Clostridioides difficile - Attributable Outcomes

Impact of Tigecycline on C. difficile Outcomes: Case Series and Propensity-Matched Retrospective Study

Binary Toxin Expression by Clostridioides difficile Is Associated With Worse Disease

Propensity-Matched Cost of Clostridioides difficile Infection Overdiagnosis

Patient Outcomes With Prevented vs Negative Clostridioides difficile Tests Using a Computerized Clinical Decision Support Tool

Collaborators (3)

Jiaming Cui

Anil Kumar Vullikanti

Costi D. Sifri

Make your next move.